BIOCARDIA ($BCDA) posted quarterly earnings results for Q4 2025 on Tuesday, March 24th. The company reported earnings of -$0.06 per share, beating estimates of -$0.17 by $0.11. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $BCDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOCARDIA Insider Trading Activity
BIOCARDIA insiders have traded $BCDA stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BCDA stock by insiders over the last 6 months:
- PETER ALTMAN (President and CEO) has made 5 purchases buying 7,000 shares for an estimated $8,288 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOCARDIA Hedge Fund Activity
We have seen 12 institutional investors add shares of BIOCARDIA stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 94,247 shares (+inf%) to their portfolio in Q4 2025, for an estimated $117,808
- DRW SECURITIES, LLC added 57,607 shares (+inf%) to their portfolio in Q4 2025, for an estimated $72,008
- VANGUARD GROUP INC added 39,063 shares (+40.5%) to their portfolio in Q4 2025, for an estimated $48,828
- GEODE CAPITAL MANAGEMENT, LLC added 27,263 shares (+70.4%) to their portfolio in Q4 2025, for an estimated $34,078
- CETERA INVESTMENT ADVISERS removed 20,275 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $26,154
- TWO SIGMA SECURITIES, LLC removed 19,337 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $24,171
- GSA CAPITAL PARTNERS LLP added 11,303 shares (+inf%) to their portfolio in Q4 2025, for an estimated $14,128
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
